Immunotech Laboratories, Inc. Enters Negotiations to Engage a Quality Person (QP) for Receipt and Distribution of Treatment inFebruary 27, 2018
Immunotech Laboratories, Inc. Receives Invitation to the 2018 Asia-Pacific Precision Medicine ForumJanuary 3, 2018
Immunotech Laboratories, Inc. / ECPO Year End Update and Announces Appointment of Dr. Hongxiang Hui to the Advisory BoardDecember 22, 2017
ECPO Files Issuers Company Related Action Notification with the Financial Industry Regulatory Authority requesting Name and SymJuly 20, 2017
ECPO-Subsidiary Immunotech Laboratories Enters Final Step of Full Commercialization by the BDA post Phase 3 Approval of ITV-1 fJune 22, 2017